吉姆·克雷默：
持有builders firstsource股票，viking therapeutics存在問題。
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
On Aug. 28, Serve Robotics announced closing of $20 million private placement & warrant exercise.On CNBC's "Mad Money Lightning Round," Jim Cramer said Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is "great."
在CNBC的「狂歡現場」中，吉姆·克雷默表示福泰製藥公司(NASDAQ: VRTX)非常出色。
On Aug. 1, Vertex Pharmaceuticals reported second-quarter revenues of $2.65 billion, almost in line with the consensus of estimate of $2.66 billion. Vertex raised its 2024 product revenue guidance from $10.55 billion-$10.75 billion to $10.65 billion-$10.85 billion.
福泰製藥於8月1日發佈了第二季度營收265億元，幾乎與預估的266億元一致。福泰製藥將2024年產品營業收入預期從105.5億美元至107.5億美元調高至106.5億美元至108.5億美元。
When asked about Serve Robotics Inc. (NASDAQ:SERV), he said, "We're not recommending companies that lose a ton of money because it's just not the right time."
當被問到是否推薦Serve Robotics公司(NASDAQ:SERV)時，他說：「因爲現在不是合適的時機，我們不建議那些虧損的公司。」
On Aug. 28, Serve Robotics announced closing of $20 million private placement & warrant exercise.
在8月28日，Serve Robotics宣佈完成了2000萬元定向增發和權證行使。
Builders FirstSource, Inc. (NYSE:BLDR) can "go higher," Cramer said, "This is precisely the kind of stock you should be buying at this stage in the cycle. Hold on."
吉姆·克雷默說，Builders FirstSource公司(NYSE:BLDR)的股價可以「上漲」，「這正是你在這個階段應該購買的股票。繼續持有。」
On Aug. 6, Builders FirstSource reported second-quarter adjusted earnings per share of $3.50, beating the street view of $3.02. Quarterly sales of $4.456 billion missed the street view of $4.483 billion.
8月6日，Builders FirstSource報道了每股調整後的第二季度收益爲3.50美元，超過了3.02美元的預期。季度銷售額4456億元低於4483億元的預期。
"Here's the problem: it costs so much money to build the factories, they're going to have to get a takeover to be able to do that," Cramer said about Viking Therapeutics, Inc. (NASDAQ:VKTX).
吉姆·克雷默談到Viking Therapeutics公司(NASDAQ:VKTX)時表示：「問題是，建廠的費用太高了，他們必須進行收購才能做到這一點。」
On July 24, Viking Therapeutics reported better-than-expected second-quarter EPS results.
7月24日，Viking Therapeutics發佈了超出預期的第二季度每股收益結果。
Price Action:
價格行動：
- Serve Robotics shares fell 1.3% to settle at $9.35 on Wednesday.
- Builders FirstSource shares fell 1% to close at $172.90.
- Vertex Pharmaceuticals shares gained 2% to close at $489.73.
- Viking Therapeutics shares fell 0.4% to settle at $61.16 on Wednesday.
- Serve Robotics股票在週三下跌1.3%，收於9.35美元。
- Builders FirstSource股票下跌1%，收於172.90美元。
- Vertex Pharmaceuticals股票上漲2%，收於489.73美元。
- Viking Therapeutics股票在週三下跌0.4%，收於61.16美元。
- Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
- 華爾街最準確的分析師聚焦於3家材料股，提供高股息回報。
資訊熱榜
更新時間